New England Securities’s Novo Nordisk NVO Stock Holding History

New England Securities’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$45K	Sell	2,142 -1,230	-36%	-$27.5K	0.02%	624
2014 Q3	$80K	Buy	3,372 +870	+35%	+$20K	0.03%	484
2014 Q2	$58K	Sell	2,502 -2	-0.1%	-$44	0.02%	575
2014 Q1	$57K	Buy	2,504 +1,244	+99%	+$26.5K	0.02%	522
2013 Q4	$23K	Buy	1,260 +590	+88%	+$10.3K	0.01%	785
2013 Q3	$11K	Hold	670	–	–	0.01%	957
2013 Q2	$10K	Buy	+670	New	+$11.2K	0.01%	876

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

New England Securities's NVO Position: Q4 2014 in Review

New England Securities reduced its Novo Nordisk (NVO) stake by 36% in Q4 2014, selling an estimated $27.5K and leaving 2,142 shares worth $45K. The position accounts for 0.02% of the portfolio, ranked #624.

New England Securities first reported a position in NVO in Q2 2013 and has held it in 7 quarters since. The position peaked at $80K in Q3 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

New England Securities held 2,142 shares of Novo Nordisk worth $45K as of Q4 2014.
New England Securities sold 1,230 Novo Nordisk shares in Q4 2014, an estimated $27.5K.
Novo Nordisk made up 0.02% of New England Securities's portfolio in Q4 2014, its #624 holding.
New England Securities first reported a position in Novo Nordisk in Q2 2013 and has held it in 7 quarters since.
New England Securities's Novo Nordisk position peaked at $80K in Q3 2014.
500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.